Lion Corporation
Lion Corporation (4912.T) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Lion Corporation (4912.T), covering cash flow, earnings, and balance sheets.
Lion Corporation (4912.T) Income Statement & Financial Overview
View the income breakdown for Lion Corporation 4912.T across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $94.24B | $111.78B | $102.53B | $105.67B |
| Cost of Revenue | $52.22B | $60.63B | $55.23B | $57.57B |
| Gross Profit | $42.02B | $51.16B | $47.30B | $48.10B |
| Gross Profit Ratio | $0.45 | $0.46 | $0.46 | $0.46 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $36.73B | $43.45B | $38.23B | $42.54B |
| Operating Expenses | $36.73B | $41.93B | $43.54B | $42.54B |
| Total Costs & Expenses | $88.95B | $102.56B | $98.77B | $100.11B |
| Interest Income | $287.00M | $767.00M | $0.00 | $724.00M |
| Interest Expense | $409.00M | $105.00M | $282.00M | $188.00M |
| Depreciation & Amortization | $5.05B | $5.52B | $5.30B | $5.14B |
| EBITDA | $10.98B | $16.80B | $8.91B | $13.60B |
| EBITDA Ratio | $0.12 | $0.15 | $0.09 | $0.13 |
| Operating Income | $5.29B | $9.22B | $9.07B | $5.56B |
| Operating Income Ratio | $0.06 | $0.08 | $0.09 | $0.05 |
| Other Income/Expenses (Net) | $227.00M | $2.72B | $313.00M | $4.14B |
| Income Before Tax | $5.51B | $11.94B | $4.07B | $9.70B |
| Income Before Tax Ratio | $0.06 | $0.11 | $0.04 | $0.09 |
| Income Tax Expense | $1.57B | $3.18B | $705.00M | $2.67B |
| Net Income | $4.03B | $8.53B | $2.73B | $6.38B |
| Net Income Ratio | $0.04 | $0.08 | $0.03 | $0.06 |
| EPS | $14.56 | $30.84 | $9.87 | $23.09 |
| Diluted EPS | $14.54 | $30.84 | $9.87 | $23.06 |
| Weighted Avg Shares Outstanding | $276.42M | $276.67M | $276.77M | $276.38M |
| Weighted Avg Shares Outstanding (Diluted) | $276.89M | $276.67M | $276.77M | $276.74M |
Over the last four quarters, Lion Corporation achieved steady financial progress, growing revenue from $105.67B in Q2 2024 to $94.24B in Q1 2025. Gross profit stayed firm with margins at 45% in Q1 2025 versus 46% in Q2 2024. Operating income totaled $5.29B in Q1 2025, maintaining a 6% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $10.98B. Net income dropped to $4.03B, with EPS at $14.56. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan